Donepezil in low micromolar concentrations modulates voltage-gated potassium currents in pyramidal neurons of rat hippocampus

被引:8
作者
Solntseva, Elena I. [1 ]
Bukanova, Julia V. [1 ]
Skrebitsky, Vladimir G. [1 ]
机构
[1] Russian Acad Med Sci, Dept Brain Res, Ctr Neurol, Moscow 109801, Russia
基金
俄罗斯基础研究基金会;
关键词
Donepezil; Hippocampus; K+-current; Pyramidal neurons; Patch clamp; SEVERE ALZHEIMERS-DISEASE; MOLLUSCAN NEURONS; CHANNELS; MEMANTINE; MECHANISM; BLOCK;
D O I
10.1016/j.bbrc.2012.12.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Donepezil is a cholinesterase inhibitor widely used for the treatment of Alzheimer's disease. Voltage-gated K+-channels are discussed as possible targets for the drug, but the results obtained by different authors are contradictory. In the present study performed on pyramidal cells isolated from rat's hippocampus, we investigated the effect of donepezil on delayed rectifier K+-current (I-K(DR)) and transient outward K+-current (I-K(A)) using patch-clamp technique. The inhibitory effect of donepezil on I-K(DR) was found in all the cells tested, but its strength varied in different cells. Two groups of neurons were differing in their sensitivity to donepezil: more sensitive (IC50 = 8.9 mu M) and less sensitive (IC50 = 114.9 mu M). The effect of the drug on I-K(DR) was rapid, reversible and voltage-dependent, increasing with depolarization. Donepezil modulated I-K(A) in two different ways: in some cells it suppressed the current with the IC50 value of 23.4 mu M, while in other cells it augmented the current with a bell-shaped dose-response curve. Maximal (about twofold) enhancement of I-K(A) amplitude was caused by 10 mu M donepezil. Augmentation of I-K(A) increased with membrane depolarization. Our results show for the first time that voltage-dependent potassium channels in mammals' neurons are effectively modulated by low micromolar concentrations of donepezil. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:1066 / 1071
页数:6
相关论文
共 23 条
[1]   Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease [J].
Chung, Kathryn A. ;
Lobb, Brenna M. ;
Nutt, John G. ;
Horak, Fay B. .
NEUROLOGY, 2010, 75 (14) :1263-1269
[2]   Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimer's Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine [J].
Doody, Rachelle S. ;
Geldmacher, David S. ;
Farlow, Martin R. ;
Sun, Yijun ;
Moline, Margaret ;
Mackell, Joan .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 (2-3) :164-173
[3]   International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels [J].
Gutman, GA ;
Chandy, KG ;
Grissmer, S ;
Lazdunski, M ;
Mckinnon, D ;
Pardo, LA ;
Robertson, GA ;
Rudy, B ;
Sanguinetti, MC ;
Stuhmer, W ;
Wang, XL .
PHARMACOLOGICAL REVIEWS, 2005, 57 (04) :473-508
[4]   IMPROVED PATCH-CLAMP TECHNIQUES FOR HIGH-RESOLUTION CURRENT RECORDING FROM CELLS AND CELL-FREE MEMBRANE PATCHES [J].
HAMILL, OP ;
MARTY, A ;
NEHER, E ;
SAKMANN, B ;
SIGWORTH, FJ .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1981, 391 (02) :85-100
[5]   Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease [J].
Howard, Robert ;
McShane, Rupert ;
Lindesay, James ;
Ritchie, Craig ;
Baldwin, Ashley ;
Barber, Robert ;
Burns, Alistair ;
Dening, Tom ;
Findlay, David ;
Holmes, Clive ;
Hughes, Alan ;
Jacoby, Robin ;
Jones, Rob ;
Jones, Roy ;
McKeith, Ian ;
Macharouthu, Ajay ;
O'Brien, John ;
Passmore, Peter ;
Sheehan, Bart ;
Juszczak, Edmund ;
Katona, Cornelius ;
Hills, Robert ;
Knapp, Martin ;
Ballard, Clive ;
Brown, Richard ;
Banerjee, Sube ;
Onions, Caroline ;
Griffin, Mary ;
Adams, Jessica ;
Gray, Richard ;
Johnson, Tony ;
Bentham, Peter ;
Phillips, Patrick .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :893-903
[6]   Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats [J].
Kosasa, T ;
Kuriya, Y ;
Matsui, K ;
Yamanishi, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 389 (2-3) :173-179
[7]   INTERNAL NA+ AND MG2+ BLOCKADE OF DRK1 (KV2.1) POTASSIUM CHANNELS EXPRESSED IN XENOPUS-OOCYTES [J].
LOPATIN, AN ;
NICHOLS, CG .
JOURNAL OF GENERAL PHYSIOLOGY, 1994, 103 (02) :203-215
[8]   POTASSIUM CHANNEL BLOCK BY CYTOPLASMIC POLYAMINES AS THE MECHANISM OF INTRINSIC RECTIFICATION [J].
LOPATIN, AN ;
MAKHINA, EN ;
NICHOLS, CG .
NATURE, 1994, 372 (6504) :366-369
[9]   Donepezil attenuates hippocampal neuronal damage and cognitive deficits after global cerebral ischemia in gerbils [J].
Min, Dongyu ;
Mao, Xiaoyuan ;
Wu, Kuncan ;
Cao, Yonggang ;
Guo, Feng ;
Zhu, Shu ;
Xie, Ni ;
Wang, Lei ;
Chen, Tianbao ;
Shaw, Chris ;
Cai, Jiqun .
NEUROSCIENCE LETTERS, 2012, 510 (01) :29-33
[10]   Sigma-1 Receptor Agonists as Therapeutic Drugs for Cognitive Impairment in Neuropsychiatric Diseases [J].
Niitsu, Tomihisa ;
Iyo, Masaomi ;
Hashimoto, Kenji .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (07) :875-883